Ansbert Gadicke

Insider Reports History

Entity
Individual
Location
The John Hancock Tower, 200 Clarendon Street, 54 Th Floor, Boston, MA
Signature
/s/ Ansbert Gadicke
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ansbert Gadicke:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Harpoon Therapeutics, Inc. 10%+ Owner Common Stock 6.33M $146M $23.00 Jun 2, 2021 Indirect
Cullinan Oncology, Inc. Director Common Stock 7.65M $95.3M $12.46 Dec 31, 2021 Indirect
iTeos Therapeutics, Inc. 10%+ Owner Common Stock 4.48M $37.5M $8.37 Jan 5, 2022 Indirect
Allovir, Inc. Director, 10%+ Owner Common Stock 16.7M $11.2M $0.67 Jul 28, 2022 By ElevateBio LLC
Repare Therapeutics Inc. 10%+ Owner Common Shares 3.88M $9.42M $2.43 Jul 12, 2021 Indirect
Cullinan Oncology, Inc. Director Common Stock 595K $7.42M $12.46 Dec 21, 2021 Direct
Allovir, Inc. Director, 10%+ Owner Common Stock 30.2K $20.3K $0.67 Jul 28, 2022 Direct
Cullinan Oncology, Inc. Director Stock Option (Right to Buy) 0 Dec 21, 2021 Direct
TCR2 THERAPEUTICS INC. Director, 10%+ Owner Common Stock 0 $1.72 Jun 1, 2023 Indirect
TCR2 THERAPEUTICS INC. Director, 10%+ Owner Common Stock Warrant (Right to Buy) 0 May 22, 2023 Indirect

Insider Reports Filed by Ansbert Gadicke

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TCRR TCR2 THERAPEUTICS INC. Jun 1, 2023 3 $0 4 Jun 5, 2023 Director, 10%+ Owner
TCRR TCR2 THERAPEUTICS INC. May 22, 2023 4 -$1 4 May 24, 2023 Director, 10%+ Owner
ALVR Allovir, Inc. Jul 28, 2022 1 $15M 4 Aug 1, 2022 Director, 10%+ Owner
CGEM Cullinan Oncology, Inc. Jun 22, 2022 1 $0 4 Jun 23, 2022 Director
ALVR Allovir, Inc. May 17, 2022 1 $0 4 May 19, 2022 Director, 10%+ Owner
ITOS iTeos Therapeutics, Inc. Jan 4, 2022 5 -$10.5M 4 Jan 6, 2022 10%+ Owner
CGEM Cullinan Oncology, Inc. Dec 31, 2021 3 $1.51M 5 Feb 10, 2023 Former Director, 10%+ Owner
ITOS iTeos Therapeutics, Inc. Dec 3, 2021 9 -$2.81M 4 Dec 7, 2021 10%+ Owner
ITOS iTeos Therapeutics, Inc. Nov 30, 2021 7 -$4.82M 4 Dec 2, 2021 10%+ Owner
ITOS iTeos Therapeutics, Inc. Nov 26, 2021 4 -$1.36M 4 Nov 30, 2021 10%+ Owner
ITOS iTeos Therapeutics, Inc. Nov 17, 2021 8 -$4.74M 4 Nov 24, 2021 10%+ Owner
ITOS iTeos Therapeutics, Inc. Oct 15, 2021 3 -$785K 4 Oct 18, 2021 10%+ Owner
ITOS iTeos Therapeutics, Inc. Oct 12, 2021 3 -$2.58M 4 Oct 14, 2021 10%+ Owner
ITOS iTeos Therapeutics, Inc. Oct 7, 2021 3 -$2.37M 4 Oct 12, 2021 10%+ Owner
ITOS iTeos Therapeutics, Inc. Oct 1, 2021 2 -$1.25M 4 Oct 5, 2021 10%+ Owner
ITOS iTeos Therapeutics, Inc. Sep 28, 2021 2 -$972K 4 Sep 30, 2021 10%+ Owner
ITOS iTeos Therapeutics, Inc. Sep 23, 2021 4 -$2.48M 4 Sep 27, 2021 10%+ Owner
ITOS iTeos Therapeutics, Inc. Sep 21, 2021 2 -$1.56M 4 Sep 23, 2021 10%+ Owner
CGEM Cullinan Oncology, Inc. Sep 16, 2021 1 $0 4 Mar 25, 2022 Director, 10%+ Owner
ITOS iTeos Therapeutics, Inc. Sep 16, 2021 4 -$4.33M 4 Sep 20, 2021 10%+ Owner
CGEM Cullinan Oncology, Inc. Sep 16, 2021 2 -$103K 4 Sep 20, 2021 Director, 10%+ Owner
ITOS iTeos Therapeutics, Inc. Sep 14, 2021 4 -$2.12M 4 Sep 16, 2021 10%+ Owner
CGEM Cullinan Oncology, Inc. Sep 14, 2021 4 -$449K 4 Sep 16, 2021 Director, 10%+ Owner
ITOS iTeos Therapeutics, Inc. Sep 9, 2021 4 -$2.73M 4 Sep 13, 2021 10%+ Owner
CGEM Cullinan Oncology, Inc. Sep 9, 2021 6 -$774K 4 Sep 13, 2021 Director, 10%+ Owner
ITOS iTeos Therapeutics, Inc. Sep 7, 2021 4 -$2.07M 4 Sep 8, 2021 10%+ Owner
CGEM Cullinan Oncology, Inc. Sep 3, 2021 6 -$1.62M 4 Sep 8, 2021 Director, 10%+ Owner
CGEM Cullinan Oncology, Inc. Aug 31, 2021 8 -$816K 4 Sep 2, 2021 Director, 10%+ Owner
CGEM Cullinan Oncology, Inc. Aug 27, 2021 4 -$1.48M 4 Aug 31, 2021 Director, 10%+ Owner
CGEM Cullinan Oncology, Inc. Aug 23, 2021 6 -$3.53M 4 Aug 25, 2021 Director, 10%+ Owner
CGEM Cullinan Oncology, Inc. Aug 11, 2021 2 -$83K 4 Aug 12, 2021 Director, 10%+ Owner
RPTX Repare Therapeutics Inc. Jul 9, 2021 3 -$2.08M 4 Jul 13, 2021 10%+ Owner
RPTX Repare Therapeutics Inc. Jun 28, 2021 3 -$654K 4 Jun 30, 2021 10%+ Owner
RPTX Repare Therapeutics Inc. Jun 24, 2021 2 -$961K 4 Jun 28, 2021 10%+ Owner
RPTX Repare Therapeutics Inc. Jun 21, 2021 5 -$1.47M 4 Jun 23, 2021 10%+ Owner
RPTX Repare Therapeutics Inc. Jun 17, 2021 4 -$1.4M 4 Jun 21, 2021 10%+ Owner
RPTX Repare Therapeutics Inc. Jun 14, 2021 2 -$207K 4 Jun 16, 2021 10%+ Owner
RPTX Repare Therapeutics Inc. Jun 8, 2021 4 -$2.09M 4 Jun 10, 2021 10%+ Owner
RPTX Repare Therapeutics Inc. Jun 3, 2021 6 -$1.86M 4 Jun 7, 2021 10%+ Owner
HARP Harpoon Therapeutics, Inc. May 28, 2021 5 -$1.19M 4 Jun 2, 2021 10%+ Owner
RPTX Repare Therapeutics Inc. May 28, 2021 4 -$1.24M 4 Jun 2, 2021 10%+ Owner
HARP Harpoon Therapeutics, Inc. May 26, 2021 2 -$347K 4 May 27, 2021 10%+ Owner
RPTX Repare Therapeutics Inc. May 25, 2021 6 -$1.27M 4 May 27, 2021 10%+ Owner
ALVR Allovir, Inc. May 25, 2021 1 $0 4 May 27, 2021 Director, 10%+ Owner
RPTX Repare Therapeutics Inc. May 21, 2021 3 -$11.3M 4 May 24, 2021 10%+ Owner
HARP Harpoon Therapeutics, Inc. May 21, 2021 2 -$321K 4 May 24, 2021 10%+ Owner
RPTX Repare Therapeutics Inc. May 18, 2021 8 -$1.61M 4 May 20, 2021 10%+ Owner
HARP Harpoon Therapeutics, Inc. May 18, 2021 3 -$982K 4 May 20, 2021 10%+ Owner
HARP Harpoon Therapeutics, Inc. May 13, 2021 3 -$329K 4 May 17, 2021 10%+ Owner
HARP Harpoon Therapeutics, Inc. May 10, 2021 5 -$1.44M 4 May 12, 2021 10%+ Owner